Search Orphan Drug Designations and Approvals
-
Generic Name: | Small molecular inhibitor of fibroblast growth factor receptor (FGFR)-1,2 and 3 tyrosine kinases |
---|---|
Date Designated: | 03/01/2022 |
Orphan Designation: | Treatment of gastric cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Abbisko Therapeutics Co.,Ltd Building 3, Lane 898, Halei Road, Zhangjiang High-Tech Park Shanghai, Shanghai 201210 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-